MNMD Mind Medicine (MindMed) Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MNMD

Price (delayed)

$9.52

Market cap

$393.5M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.44

Enterprise value

$307.93M

Highlights
The net income has dropped by 69% year-on-year and by 25% since the previous quarter
MNMD's quick ratio has plunged by 61% YoY and by 18% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OMER OMGA

Key stats

What are the main financial stats of MNMD
Market
Shares outstanding
41.33M
Market cap
$393.5M
Enterprise value
$307.93M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.89
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$95.73M
EBITDA
-$92.57M
Free cash flow
-$64.37M
Per share
EPS
-$2.44
Free cash flow per share
-$1.64
Book value per share
$1.95
Revenue per share
$0
TBVPS
$2.66
Balance sheet
Total assets
$124.54M
Total liabilities
$46.41M
Debt
$14.13M
Equity
$78.13M
Working capital
$71.63M
Liquidity
Debt to equity
0.18
Current ratio
3.22
Quick ratio
3.09
Net debt/EBITDA
0.92
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-67.9%
Return on equity
-93.3%
Return on invested capital
N/A
Return on capital employed
-103.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNMD stock price

How has the Mind Medicine (MindMed) stock price performed over time
Intraday
0.95%
1 week
11.74%
1 month
-3.35%
1 year
153.87%
YTD
160.11%
QTD
1.28%

Financial performance

How have Mind Medicine (MindMed)'s revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$93.87M
Net income
-$95.73M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 69% year-on-year and by 25% since the previous quarter
The operating income has declined by 42% year-on-year and by 10% since the previous quarter

Growth

What is Mind Medicine (MindMed)'s growth rate over time

Valuation

What is Mind Medicine (MindMed) stock price valuation
P/E
N/A
P/B
4.89
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 33% YoY and by 30% QoQ
Mind Medicine (MindMed)'s equity has decreased by 48% YoY and by 19% from the previous quarter

Efficiency

How efficient is Mind Medicine (MindMed) business performance
The ROE has dropped by 132% year-on-year and by 47% since the previous quarter
MNMD's ROA has plunged by 90% YoY and by 35% from the previous quarter

Dividends

What is MNMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNMD.

Financial health

How did Mind Medicine (MindMed) financials performed over time
Mind Medicine (MindMed)'s total assets is 168% more than its total liabilities
The total liabilities has soared by 143% YoY
MNMD's quick ratio has plunged by 61% YoY and by 18% from the previous quarter
The debt is 82% smaller than the equity
Mind Medicine (MindMed)'s equity has decreased by 48% YoY and by 19% from the previous quarter
Mind Medicine (MindMed)'s debt to equity has increased by 20% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.